UKTI Logo
globe South Korea | Trade Services
Help
Text size: a  a  a Home
Global Gateway
About Us
Who We Are Minister of State CEO Business Ambassadors
How We Help
Businesses Consultants Press Students
Contact Us
Global Offices
Events
Upcoming events Event coverage
Downloads
UKTI publications Information sheets Investor case studies FAQs Maps Partner publications Presentations Video
OurWorld  
 
 
My UK
Create email alerts
 
Why the UK?
Key advantages Business factors
UK economy Regulation Tax environment R&D Immigration Finance and incentives Commercial property Skills and employment Importing and exporting Intellectual property
Investment regions
East of England East Midlands London Northern Ireland North East England North West England Scotland South East England South West England Wales West Midlands Yorkshire and the Humber
Forming a company Living & leisure
 
Your business sector
Aerospace Automotive Creative industries Environment & renewable energy Financial & Business Services
Financial services Business Services
Food & drink ICT
Electronics Software & IT Services Telecommunications
Life sciences
Biotech & Pharma Healthcare & medical
Nanotechnology More sectors
 
UK advisory network
Get professional advice
Biotech & Pharma

UK biotechnology & pharmaceuticals opportunities

The UK is one of the world’s most attractive locations for international pharmaceutical and biotechnology operations.

UK companies account for 40 per cent of biotechnology products in the pipeline by European public companies.

Moreover, 45 per cent of new biotechnology drugs in late-stage clinical trials (Phase III) in Europe are from the UK.

The UK is also the world’s number-two pharmaceuticals exporter and, with R&D investment of over £3.3 billion in 2005, it ranks with the USA and Japan as one of the top three centres for pharmaceutical research.

To read our Inward Investment Report 2008/9 in Life Sciences, click here.

Find the top 10 reasons for undertaking clinical research and trials in the UK.

Get information on developing regenerative medicines in the UK.

Or read case studies for international biotech & pharma companies that are already doing business in the UK.

Related articles

Image of Science & Technology Facilities Council managers welcoming Byotrol scientists to their new R&D laboratory

image Bug-battling company relocates research in the UK

04-Feb-2010 A pioneering innovation centre in England is helping to attract companies to locate their research and development efforts in the UK.

Image of substance being inserted into test tubes for medical research

image In fine health: Yorkshire biotech and pharma

26-Jan-2010 Yorkshire and the Humber is home to one of the fastest-developing biotechnology, pharmaceutical and healthcare technology sectors in the UK.

Image of a male engineer at work

image The rise of UK infotech companies

07-Jan-2010 Thousands of new-technology firms are predicted to set up in business in the UK, creating as many as 80,000 IT jobs to service them, according to a leading figure in the industry.

Professor Zhanfeng Cui (left) and Dr Tim Hart pictured next to a microscope used to monitor stem cells. Image by University of Oxford

image China invests in world-class research at Oxford

04-Nov-2009 An innovative UK company has secured a £1 million investment from Hong Kong for its micro-bioreactor technology, the first time a Chinese investor has provided funding for an Oxford University spin-out company.

image The Heart of UK Pharma

02-Nov-2009 The heart of the UK's world-leading pharma industry can be found in the East of England.

An image of a UK scientist

image Redefining our biology: the UK's regenerative medicine sector

16-Oct-2009 Regenerative medicine is set to revolutionise 21st century healthcare.

An image of UK research specialist

image Stemming the tide: the UK’s groundbreaking diabetic research

16-Oct-2009 UK academic institutions and biotech companies have been making significant breakthroughs to stem the tide of a worldwide diabetes epidemic.

An image of a doctor and patient

image Heart of the matter: UK at the forefront of cardiovascular research

16-Oct-2009 The UK’s expertise in the field of cardiovascular research and development has long been acknowledged internationally.



Page 1 of: |1 |2 |3 Next>

imagePrintable Version
Email this pageEmail this page
imageAdd to My UK

Page 1 of: |1 |2 |3 Next>

Last updated:
04-Feb-2010

Business Support

Tom Matlock

Head of Inward Investment

British Embassy, Seoul

Tel: +82 2 3210 5610

Send me an email

Showcasing the UK Biotechnology and Pharmaceutical Industry

The UK is a centre of excellence and expertise for the Biotechnology and Pharmaceuticals sector. View a short video highlighting the UK’s many successes in this field.